1944 19. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Jüppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML, Osteoporosis-Pseudoglioma Syndrome Collaborative Group (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513–523 20. Burnham JM, Shults J, Weinstein R, Lewis JD, Leonard MB (2006) Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database. Ann Rheum Dis 65(8):1074–1079 21. Cheung WW, Paik KH, Mak RH (2010) Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol 25(4):711– 724 22. Mak RH, Cheung W (2007) Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Curr Opin Nephrol Hypertens 16(1):27–31 23. Strassburg S, Anker SD (2006) Metabolic and immunologic derangements in cardiac cachexia: where to from here? Heart Fail Rev 11(1):57–64 24. Saito M, Marumo K (2010) Collagen cross-links as a determi- nant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21 (2):195–214 25. Saito M, Shiraishi A, Ito M, Sakai S, Hayakawa N, Mihara M, Marumo K (2010) Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model. Bone 46(4):1170–1179 26. Doorenbos CR, van den Born J, Navis G, de Borst MH (2009) Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol 5 (12):691–700 27. Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G (2006) Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regu- lates FGF23 production in osteoblasts. J Clin Invest 116 (12):3150–3159 28. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281 29. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG, Iowa Women's Health Study (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50:72–77 30. Rauch F, Schoenau E (2001) The developing bone: slave or master of its cells and molecules? Pediatr Res 50:309–314 31. Frost HM, Schönau E (2000) The “muscle-bone unit” in children and adolescents: a 2000 overview. J Pediatr Endocrinol Metab 13:571–590 32. Krølner B, Toft B, Pors Nielsen S, Tøndevold E (1983) Physical exercise as prophylaxis against involutional vertebral bone loss: a controlled trial. Clin Sci 64:541–546 33. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481–1488 34. Zwerina J, Redlich K, Polzer K, Joosten L, Krönke G, Distler J, Hess A, Pundt N, Pap T, Hoffmann O, Gasser J, Scheinecker C, Pediatr Nephrol (2011) 26:1937–1946 Smolen JS, van den Berg W, Schett G (2007) TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci USA 104:11742–11747 35. Canaff L, Zhou X, Hendy GN (2008) The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3. Biol Chem 283 (20):13586–13600 36. Canaff L, Hendy GN (2005) Calcium-sensing receptor gene transcription is up-regulated by the proinflammatory cytokine, interleukin-1beta. Role of the NF-kappaB PATHWAY and kappaB elements. J Biol Chem 280(14):14177–14188 37. Halton JM, Atkinson SA, Fraher L, Webber C, Gill GJ, Dawson S, Barr RD (1996) Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 11:1774–1783 38. Reid IR (1998) Glucocorticoid effects on bone. J Clin Endo- crinol Metab 83:1860–1862 39. Wong MM, Rao LG, Ly H, Hamilton L, Tong J, Sturtridge W, McBroom R, Aubin JE, Murray TM (1990) Long-term effects of physiologic concentrations of dexamethasone on human bone- derived cells. J Bone Miner Res 5:803–813 40. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mecha- nisms of their deleterious effects on bone. J Clin Invest 102:274– 282 41. Seene T (1994) Turnover of skeletal muscle contractile proteins in glucocorticoid myopathy. J Steroid Biochem Mol Biol 50:1–4 42. Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA (2004) Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med 351:868–875 43. Wetzsteon RJ, Shults J, Zemel BS, Gupta PU, Burnham JM, Herskovitz RM, Howard KM, Leonard MB (2009) Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome. J Bone Miner Res 24 (3):503–513 44. Walsh NC, Crotti TN, Goldring SR, Gravallese EM (2005) Rheumatic diseases: the effects of inflammation on bone. Immunol Rev 208:228–251 45. Ginaldi L, Di Benedetto MC, De Martinis M (2005) Osteopo- rosis, inflammation and ageing. Immun Ageing 2:14 46. Campisi G, Chiappelli M, De Martinis M, Franco V, Ginaldi L, Guiglia R, Licastro F, Lio D (2009) Pathophysiology of age- related diseases. Immun Ageing 6:12 47. van den Berg WB (2009) Lessons from animal models of arthritis over the past decade. Arthritis Res Ther 11(5):250 48. Yen ML, Tsai HF, Wu YY, Hwa HL, Lee BH, Hsu PN (2008) TNF-related apoptosis-inducing ligand (TRAIL) induces osteo- clast differentiation from monocyte/macrophage lineage precur- sor cells. Mol Immunol 45(8):2205–2213 49. Burnham JM, Shults J, Dubner SE, Sembhi H, Zemel BS, Leonard MB (2008) Bone density, structure, and strength in juvenile idiopathic arthritis: importance of disease severity and muscle deficits. Arthritis Rheum 58(8):2518–2527 50. Fournier C (2005) Where do T cells stand in rheumatoid arthritis? Joint Bon Spine 72:527–532 51. Viswanathan A, Sylvester FA (2008) Chronic pediatric inflamma- tory disease: effects on bone. Rev Endocr Metab Disord 9:107–122 52. McKenzie BS, Kastelein RA, Cua DJ (2006) Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27:17–23 53. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345–1352